saline placebo-University of Saskatchewan-COVID-19

This is a saline placebo control used in clinical trials conducted by the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO). Specifically, it was utilized in the Phase 1 COVAC-005 clinical trial to evaluate the safety and immunogenicity of the COVAC-1 protein subunit COVID-19 booster vaccine in healthy adults. The placebo consists of a sterile saline solution (salt water) without any active pharmaceutical ingredients, antigens, or adjuvants. It is administered via intramuscular injection to a control group to provide a baseline for comparison against the investigational COVAC-1 vaccine's safety profile and immune response.

Other names

Saline Placebosaline solution